Viewing Study NCT05322720


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-06-26 @ 4:51 AM
Study NCT ID: NCT05322720
Status: UNKNOWN
Last Update Posted: 2022-04-12
First Post: 2022-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy
Sponsor: Taizhou EOC Pharma Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor, Adult View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View